Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Apr 12;134(1):393–400. doi: 10.1007/s10549-012-2058-9

Table 3.

Number of unfavorable alleles in telomere maintenance genes and all-cause or breast cancer-specific mortality after 8 years of follow-up among a population-based cohort of women diagnosed with breast cancer in 1996–1997, Long Island Breast Cancer Study Project.

No of Unfavorable alleles/genotypes* Telomere length (T/S ratio)** No. of cases All-cause mortality Breast cancer-specific mortality

Deaths HR (95% CI) # Deaths HR(95% CI) #
0–1 1.09 163 20 1.00 8 1.00
2–3 1.03 520 90 1.36 (0.84–2.21) 54 2.15 (1.02–4.51)
4–5 1.02 218 61 2.24 (1.35–3.72) 35 3.53 (1.64–7.62)
*

Carrying PINX1-33 G-allele, POT1-18 T-allele, TERF2-03 GG, TERT-14 CC, and TERT-67 TT genotypes;

**

Means

#

Adjusted for age at diagnosis as continuous, HR = 1.54 (95%CI: 1.22–1.96) for all-cause

mortality, Ptrend = 0.0004; HR = 1.78 (95%CI: 1.30–2.45) for breast cancer-specific mortality, Ptrend = 0.0004